| Literature DB >> 29160130 |
Rinne M Peters1,2, Liza N Van Steenbergen3, Martin Stevens2, Paul C Rijk1, Sjoerd K Bulstra2, Wierd P Zijlstra1.
Abstract
Background and purpose - Alternative bearing surfaces such as ceramics and highly crosslinked polyethylene (HXLPE) were developed in order to further improve implant performance of total hip arthroplasties (THAs). Whether these alternative bearing surfaces result in increased longevity is subject to debate. Patients and methods - Using the Dutch Arthroplasty Register (LROI), we identified all patients with a primary, non-metal-on-metal THA implanted in the Netherlands in the period 2007-2016 (n = 209,912). Cumulative incidence of revision was calculated to determine differences in survivorship of THAs according to bearing type: metal-on-polyethylene (MoPE), metal-on-HXLPE (MoHXLPE), ceramic-on-polyethylene (CoPE), ceramic-on-HXLPE (CoHXLPE), ceramic-on-ceramic (CoC), and oxidized-zirconium-on-(HXL)polyethylene (Ox(HXL)PE). Multivariable Cox proportional hazard regression ratios (HRs) were used for comparisons. Results - After adjustment for confounders, CoHXLPE, CoC, and Ox(HXL)PE resulted in a statistically significantly lower risk of revision compared with MoPE after 9 years follow-up (HR =0.8-0.9 respectively, compared with HR =1.0). For small (22-28 mm) femoral head THAs, lower revision rates were found for CoPE and CoHXLPE (HR =0.9). In the 36 mm femoral head subgroup, CoC-bearing THAs had a lower HR compared with MoHXLPE (HR =0.7 versus 1.0). Crude revision rates in young patients (< 60 years) for CoHXLPE, CoC, and Ox(HXL)PE (HR =0.7) were lower than MoPE (HR =1.0). However, after adjustment for case mix and confounders these differences were not statistically significant. Interpretation - We found a mid-term lower risk of revision for CoHXLPE, CoC, and Ox(HXL)PE bearings compared with traditional MoPE-bearing surfaces.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29160130 PMCID: PMC5901513 DOI: 10.1080/17453674.2017.1405669
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Reasons for revision or reoperation in revised THAs performed in 2007–2016 in the Netherlands (n = 6,515)
| Revision within follow-up period | MoPE (n = 1,023) | MoHXLPE (n = 890) | CoPE (n = 1,186) | CoHXLPE (n = 1,649) | CoC (n = 454) | Ox(HXL)PE (n = 262) | Totalc (n = 5,464) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
| Dislocation | 391 | 38 | 248 | 28 | 393 | 33 | 498 | 30 | 91 | 20 | 60 | 23 | 1681 | 31 |
| Loosening of acetabulum | 190 | 19 | 97 | 11 | 171 | 14 | 162 | 9.8 | 46 | 10 | 39 | 15 | 705 | 13 |
| Infection | 163 | 16 | 165 | 19 | 180 | 15 | 330 | 20 | 51 | 11 | 35 | 13 | 924 | 17 |
| Loosening of femur | 145 | 14 | 213 | 24 | 262 | 22 | 323 | 20 | 112 | 25 | 69 | 26 | 1124 | 21 |
| Periprosthetic fracture | 106 | 10 | 166 | 19 | 118 | 9.9 | 283 | 17 | 42 | 9.3 | 59 | 23 | 774 | 14 |
| Cup/liner wear | 27 | 2.6 | 17 | 1.9 | 30 | 2.5 | 29 | 1.8 | 15 | 3.3 | 9 | 3.4 | 127 | 2.3 |
| Girdlestone | 35 | 3.4 | 32 | 3.6 | 44 | 3.7 | 52 | 3.2 | 14 | 3.1 | 9 | 3.4 | 186 | 3.4 |
| Periarticular ossification | 12 | 1.2 | 19 | 2.1 | 36 | 3.0 | 23 | 1.4 | 8 | 1.8 | 2 | 0.8 | 100 | 1.8 |
| Other | 158 | 15 | 133 | 15 | 182 | 15 | 249 | 15 | 133 | 29 | 39 | 15 | 894 | 16 |
C – ceramic, HXL – highly crosslinked, M – metal, Ox – oxidized zirconium, PE – polyethylene.
p < 0.001 between different bearing types.
A patient may have more than 1 reason for revision or reoperation. As such, the total is over 100%.
Crude cumulative incidence of revision in THAs performed in 2007–2016 in the Netherlands
| Revision for any reason | MoPE (n = 37,351) % (CI) | MoHXLPE (n = 32,867) % (CI) | CoPE (n = 40,109) % (CI) | CoHXLPE (n = 70,175) % (CI) | CoC (n = 17,625) % (CI) | Ox(HXL)PE (n = 11,785) % (CI) |
|---|---|---|---|---|---|---|
| 5 year | 2.7 (2.5–2.9) | 3.3 (3.1–3.5) | 3.0 (2.8–3.2) | 2.9 (2.7–3.0) | 2.8 (2.5–3.0) | 2.5 (2.2–2.8) |
| 9 year | 3.9 (3.6–4.2) | 4.2 (3.8–4.6) | 4.0 (3.7–4.3) | 4.0 (3.6–4.4) | 4.1 (3.4–4.9) | 3.5 (3.0–4.1) |
For abbreviations, see Table 1.
Figure 1.Cumulative incidence of revision according to bearing type of THA in the Netherlands in the period 2007–2016.
Multivariable survival analyses of patients with a THA in the period 2007–2016 in the Netherlands (n = 209,912)
| Articulation | Crude hazard ratio for revision (CI) | Adjusted hazard ratio for revision |
|---|---|---|
| MoPE | 1.0 | 1.0 |
| MoHXLPE | 1.18 (1.08–1.29) | 0.98 (0.88–1.09) |
| CoPE | 1.08 (0.99–1.17) | 0.99 (0.90–1.08) |
| CoHXLPE | 1.08 (1.00–1.17) | 0.87 (0.79–0.96) |
| CoC | 1.01 (0.91–1.13) | 0.82 (0.71–0.94) |
| Ox(HXL)PE | 0.94 (0.82–1.08) | 0.81 (0.70–0.94) |
For abbreviations, see Table 1.
Adjusted for age at surgery, sex, ASA score, diagnosis, previous operation, fixation, head diameter, surgical approach, and period.
p < 0.05.
p < 0.001.
Figure 2.Cumulative incidence of revision according to bearing type for patients aged younger than 60.
Multivariable survival analysis of patients with different femoral head components
| Femoral head Articulation | n (revisions) | Crude hazard ratio for revision (CI) | Adjusted hazard ratio |
|---|---|---|---|
| 22–28 mm (n = 73,114) | |||
| MoPE | 27,423 (843) | 1.0 | 1.0 |
| MoHXLPE | 7,236 (256) | 1.3 (1.2–1.5)c | 1.1 (1.0–1.3) |
| CoPE | 22,165 (660) | 1.0 (0.9–1.1) | 0.9 (0.8–1.0) |
| CoHXLPE | 14,188 (367) | 1.1 (1.0–1.2) | 0.9 (0.7–1.0) |
| CoC | 1,406 (42) | 1.0 (0.7–1.4) | 0.8 (0.6–1.1) |
| Ox(HXL)PE | 696 (17) | 0.8 (0.5–1.4) | 0.7 (0.5–1.2) |
| 32 mm (n = 96,330) | |||
| MoPE | 9,908 (179) | 1.0 | 1.0 |
| MoHXLPE | 17,248 (377) | 1.4 (1.1–1.6) | 1.1 (0.9–1.3) |
| CoPE | 17,888 (525) | 1.5 (1.3–1.8) c | 1.3 (1.1–1.6) |
| CoHXLPE | 40,496 (877) | 1.3 (1.1–1.6) | 1.0 (0.9–1.2) |
| CoC | 3,279 (99) | 1.5 (1.2–1.9) | |
| Ox(HXL)PE | 7,511 (158) | 1.1 (0.9–1.4) | 0.9 (0.8–1.2) |
| 36 mm (n = 39,017) | |||
| MoPE | 13 (0) | n.a. | n.a. |
| MoHXLPE | 8,124 (253) | 1.0 | 1.0 |
| CoPE | 56 (1) | n.a. | n.a. |
| CoHXLPE | 15,490 (405) | 1.0 (0.8–1.1) | 0. 9 (0.8–1.1) |
| CoC | 11,756 (280) | 0.8 (0.6–0.9) | 0.7 (0.6–0.9) |
| Ox(HXL)PE | 3,578 (87) | 0.9 (0.7–1.2) | 0.9 (0.7–1.1) |
Adjusted for sex, ASA score, diagnosis, previous operation, fixation, surgical approach, and period.
p < 0.05.
p < 0.001.
n.a. = not applicable; hazard ratios and confidence intervals for the MoPE and CoPE articulation were not applicable due to small number of revisions.